1832 Asset Management
ONC

1832 Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

1832 Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-80,000
Closed -$27.3M – 778
2025
Q3 		$27.3M Buy
+80,000
New +$24.3M 0.02% 243
2023
Q1 		– Sell
-800
Closed -$176K – 992
2022
Q4 		$176K Buy
800
+742
+1,279% +$136K ﹤0.01% 699
2022
Q3 		$8K Buy
+58
New +$9.96K ﹤0.01% 813
2021
Q4 		– Sell
-30,800
Closed -$11.2M – 880
2021
Q3 		$11.2M Sell
30,800
-2,000
-6% -$654K 0.02% 319
2021
Q2 		$11.7M Buy
32,800
+2,500
+8% +$828K 0.02% 293
2021
Q1 		$10.1M Buy
30,300
+4,000
+15% +$1.32M 0.02% 290
2020
Q4 		$6.73M Buy
+26,300
New +$7.24M 0.02% 328

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

1832 Asset Management's ONC Position: Q4 2025 in Review

1832 Asset Management sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 80,000 shares — an estimated $27.3M sold.

1832 Asset Management first reported a position in ONC in Q4 2020 and held it in 7 quarters. The position peaked at $27.3M in Q3 2025. 285 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • 1832 Asset Management reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • 1832 Asset Management sold 80,000 BeOne Medicines Ltd shares in Q4 2025, an estimated $27.3M.
  • 1832 Asset Management first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 7 quarters.
  • 1832 Asset Management's BeOne Medicines Ltd position peaked at $27.3M in Q3 2025.
  • 285 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on 1832 Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.